ProteinType:
Protease
Source:
E.coli
SpecificActivity:
>1Units/µg.1UnitsofTurbo3C(HRV3C)Proteasecleaves>95%of100µgoftargetproteinat4oCfor16hours.
Storage/Handling:
Storeat-80oC.
2mg/mlin50mMTris-HCl,pH8.0,150mMNaCl,1mMEDTA,1mMTCEP,50%glycerol
| A68kDaGST-fusionprotein(C)at1mg/mlisincubatedwithTurbo3C(HRV3C)Protease(*)ataratioof(1)1:50,(2)1:100,(3)1:200,(4)1:400(w/w)inabufferof25mMTris-HCl,pH8.0,150mMNaCl,14mMb-mercaptoethanolat4oCfor16hours.Thecleavedproductsare42kDaand26kDa |
CleavageinSolution
- MakefreshcoldDialysisBuffer.DialysisBuffershouldbeabufferinwhichthetargetproteinissoluble.ThereshouldbenoproteaseinhibitorintheDialysisBuffer.TheDialysisBuffershouldbecompatIBLewithdownstreampurificationprocesses,e.g.minimalamountofEDTAorDTTifNicolumnwillbeusedtoremovethecleavedHis-tag.
HereisanexampleofDialysisBuffer.25mMTris-HCl,pH8.0,150-500mMNaCl,14mMb-mercaptoethanol
Turbo3Chasthesameactivityin150mMNaClor500mMNaCland400mMimidazole.
- Dilutetheproteinpoolto1-2mg/mlwithDialysisBuffer.ThisisoptionalincasethetargetproteinaggregatesinDialysisBuffer.SaveasmallaliquotasUncutsampleforanalysis.EDTAmaybeaddedto0.5mMfinalconcentrationifthetargetproteinpooliselutedfromNicolumnandEDTAiscompatiblewiththetargetprotein.
- AddTurbo3CProteaseataProtease:targetproteinratioof1:100(w/w)or1,000unitTurbo3CProteaseto100mgoftargetprotein.Thereisnoneedtocalculatethemolarratio.Turbo3CProteasecanbeaddeddirectlytothetargetprotein.ThereisnoneedtochangebufferordiluteTurbo3CProtease.Theoptimalratioshouldbedeterminedempirically.AProtease-to-targetproteinratio(w/w)of1:50to1:200shouldworkformosttargetproteins.
- DialyzeagainsttheDialysisBufferat4oCovernight(about16hrs).DialysisistoremoveimidazoleorglutathioneifNiorglutathionecolumnisusedtoremovethecleavedtagorTurbo3CProteaseaftercleavage.Ifdesired,thetargetproteinpoolcanbebufferexchangedfirstbeforeRurbo3Ccleavage.
RemovalofTurbo3CProtease
- ThedialyzedtargetproteinandTurbo3CProteasemixturecanbeapplieddirectlytoaffinitycolumnsifcompatibleDialysisBufferisused.ForHis-taggedprotein,useIMACtoremovethecleavedHis-tagandTurbo3CProtease.ForGST-taggedprotein,useglutathionecolumntoremovethecleavedGST-tagandTurbo3CProtease.
- Ifdesired,analyzesamplesusingSDS-PAGEanalysis.ThedifferencebetweenthetaggedandcleavedtargetproteinmaybetoosmalltodetectbySDS-PAGE.ThecleavedHis-tagsometimescanbeseenatthebottomofthegel.
VishwanathaKBackN,MainsRE,EipperBA..AHistidine-richLinkerRegioninPeptidylglycineAlpha-AmidatingMonooxygenasehasthePropertiesofapH-sensor.JBiolChem.2014Mar13.
KurutihalliVishwanatha,NilsBack,RichardE.MainsandBettyA.Eipper.Ahistidine-richlinkerregioninPeptidylglycinealpha-amidatingMonoocygenasehasthepropertiesofapH-sensor.TheJournalofBIOLOGicalChemistry,289,12404-12420.
Everest Biotech公司成立于2000年,由英国牛津大学一批生物化学家创建。公司科学家团队具有丰富的抗体纯化及蛋白组学专业知识,雄厚的专业背景赋予了公司能为全球科研人员提供高质量、创新性抗体产品的能力。目前,Everest Biotech可提供3000余种抗体,涉及肿瘤、自身免疫、过敏、心血管疾病、传染病、代谢、神经科学等领域。所有抗体均由Everest Biotech自主研发生产、全部经过肽亲和纯化以保证最佳的特异性和纯度、经过免疫原肽的ELISA和WB实验验证; 由PhD科学家团队提供全方位技术支持服务。Everest Biotech为众多国际知名抗体公司提供OEM服务。